Tomoki Yoneyama

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of <scp>TAK</scp>‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects

Helen Jenkins, Yuichi Sakurai, Akira Nishimura et al. · Alimentary Pharmacology & Therapeutics · 2015 · 307 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +8

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects

Yuuichi Sakurai, Akira Nishimura, Gale Kennedy et al. · Clinical and Translational Gastroenterology · 2015 · 190 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

A validated simultaneous quantification method for vonoprazan (TAK-438F) and its 4 metabolites in human plasma by the liquid chromatography-tandem mass spectrometry

Tomoki Yoneyama, Koichiro Teshima, Fumihiro Jinno et al. · Journal of Chromatography B · 2016 · 40 citations

Life Sciences, Pharmaceutical Analysis, Pharmacology +16

Advanced translational PBPK model for transferrin receptor-mediated drug delivery to the brain

Sho Sato, Siyu Liu, Akihiko Goto et al. · Journal of Controlled Release · 2023 · 26 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Nicotinic acetylcholine receptors expressed in the ventralposterolateral thalamic nucleus play an important role in anti‐allodynic effects

Masashi Ueda, Yuki Iida, Akiko Tominaga et al. · British Journal of Pharmacology · 2010 · 24 citations · Full text

Medicine, Neuroscience, Pharmacology +17